Association of obesity and depression;Az elhízás és a depresszió kapcsolatai

Neuropsychopharmacologia Hungarica

Volumn 10, Issue 4, 2008, Pages 183-189

  Zoltán, Rihmer ^a   György, Purebl ^a   Gábor, Faludi ^a   László, Halmy ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Magatartástudományi Intézet ^*  (Hungary)

Author keywords

Bipolar disorder; Circadian rhythm; Depression; Life style; Obesity; Psychopharmacons

Indexed keywords

ANOREXIGENIC AGENT; ANTIDEPRESSANT AGENT; ANTIOBESITY AGENT; CYCLOBUTANE DERIVATIVE; GHRELIN; LEPTIN; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; RIMONABANT; SIBUTRAMINE;

BIPOLAR DISORDER; BLOOD; CALORIC INTAKE; CARBOHYDRATE DIET; CIRCADIAN RHYTHM; DEPRESSION; FOOD INTAKE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN RESISTANCE; MAJOR DEPRESSION; METABOLISM; OBESITY; QUESTIONNAIRE; REVIEW; SEASONAL AFFECTIVE DISORDER; SLEEP DISORDER; WEIGHT GAIN; WEIGHT REDUCTION;

ANTI-OBESITY AGENTS; ANTIDEPRESSIVE AGENTS; APPETITE DEPRESSANTS; APPETITE REGULATION; BIPOLAR DISORDER; CIRCADIAN RHYTHM; CYCLOBUTANES; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DIETARY CARBOHYDRATES; ENERGY INTAKE; GHRELIN; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN RESISTANCE; LEPTIN; OBESITY; PIPERIDINES; PITUITARY-ADRENAL SYSTEM; PYRAZOLES; QUESTIONNAIRES; SEASONAL AFFECTIVE DISORDER; SLEEP DISORDERS; WEIGHT GAIN; WEIGHT LOSS;

EID: 63349087646     PISSN: 14198711     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Akiskal HS, Hantouche EG, Allilare JF, Bipolar II with and without cyclothymic temperament: "Dark" and "sunny" expressions of soft bipolarity. J Affect Disord, 2003; 73: 49-57.
2. Binkey K, Knowles SR. Sibutramine and panic attacks. Amer J Psychiatry, 2002; 159: 1793-1794.
3. Cardenas J. Frye MA, Marusak SL, Levander EM, Chirichango JW, Lewis S, Nakelsky S, Hwang S, Mintz J, Altshuler LL. Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J Affect Disord, 2008; 106: 91-97
4. Chrousos GP. The role of stress ad the hypohtalamic-pitutary-andreanl axis in the pathogenesis of the metabolic syndrome: neuro-edocrine and target tissue-related causes. Int J obes Relat Metab Disord 2000; 24S: 50-5
5. Cordeiro Q, Vallada H. sibutramineinduced manic episode in a bipolar patient. Int J Neuropsychopharmacol. 2002; 5: 283-284.
6. Dépres J-P. Golay A, Sjöström L, és a Rimonabant in Obesitys-Lipids Study Group. Effects of rimonabant on metabolic risk factors in owerveight patients with dyslipidemia. N Engl J Med 2005; 353: 2121-2134.
7. Duman RS. Neurotrophic factors and regulation of mood: Role of diet, excercise and metabolism. Neurobiology of Aging 2005; 26S 88-93.
8. Everson-Rose SA, Meyer PM, Powell LH, Pandey D, Torrens JI, Kravitz HM, Bromberger JT, Matthews KA. Derpessive symptos, insuoin resistance and risk of diabetes in women at midlife. Diabetes Care 2004; 27: 2856-62
9. Fagiolini A,. Frank E, Houck PR, Mallinger AG, Swartz HA, Buysse DJ, Ombao H, Kupfer DJ. Prevalence of obestiy and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry, 2002; 63: 528-533.
10. Garcia-Portilla MP, Saiz PA, Benabarre A, Sierra P, Perez J, Rodriguez A, Livianos L, Torres P, Bobes J. The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord, 2008; 106: 197-201.
11. Gazdag G, Szabó Zs. Sibutramineassociated psychosis (Case Report) Neuropsychopharmacol. Hung. 2008; 10: 107-110.
12. Gogerty JH. és Trapold JH. Chemistry and pharmacology of mazindol. Triangle, 1976; 15: 25-36.
13. Goodwin FK, és Jamison KR, Manic-Depressive Illness. Bipolar Disorders and Recurrent Depression. Oxford University Press, New York, 2007.
14. Harris AHS, Cronkite R, Moos R. Physical activity, excercise coping and depression in a 10-year cohort study of depressed patients. J Affect Disord 2006; 93: 79-85
15. Henquet C, Krabbendam L, de Graaf R, ten Have M, van Os J,: Cannabis use and the expression of mania in the general population. J. Affect. Disord. 2006; 95: 103-110.
16. Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP. Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 2004; 66: 316-22
17. Kim B, Kim S-J, Son J-I, Joo YH, Weight change in the acute treatment of bipolar I disorder: A naturalistic observational study of psychiatric inpatient. J Affect Disord, 2008; 105: 45-52.
18. Kochman FJ, Hantouche EG, Ferrari P, Lancrenon P, Bayart D, Akiskal HS, Cyclothymic temperament as a prospective predictos of bipolarity and suicidality in children and adolescents with major depressive disorder. J Affect Disord, 2005; 85: 181-189.
19. Kopp M, Skrabski Á. Magyar lelkiállapot. Végeken Kiadó, Budapest, 1992.
20. Lader M. Limitations of current medical treatments of depression: disturbed circadian rhythm as a possible therapeutic target. European psychopharmacology 2007; 17: 743-755
21. Lütjohann D. Brain cholesterol and suicidal nehaviour. Int. J Neuropsychopharmacol, 2007; 10: 153-157.
22. McElroy SI, Frye MA, Suppes T, Dhvavle D, Keck PE, Leverich GS, Altshuler L, Denicoff KD, Nolen WA, Kupka R, Grunze H, Walden J, Post RM. Correlates of owerweight and obestiy in 644 patients with bipolar disoder. J Clin Psychiatry, 2002; 63: 207-213.
23. McNeely W, és Goa KL. Sibutramine: A review of its contribution to the management of obesity. Drugs, 1998; 56: 1093-1124.
24. Meisinger C, Heier M, Loewel H, and the MONICA/KORA Cohort Study. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 2005; 48: 235-241
25. Murray, CJL, Lopez, AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet, 1997, 349: 1498-1054.
26. Pompili M, Rihmer Z, Akiskal HS, Innamorati M, Iliceto P, Aksikal KK, Lestar D, Narciso V, Ferracuti S, Tatarelli R, De Pisa E, Girardi P. Temperament and personality dimensions in suicidal and nonsuicidal psychiatric inpatients. Psychopathology 2008; 41: 313-321
27. Parker G, Gibson NA, Heruc G, Rees A-M, Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Amer J Psychiatry, 2006; 163: 969-978.
28. Pi-Sunyer FX., Aronne LJ, Heshmati LS. Et al. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and caridiometabolic risk factors in overweight or obese patients: RIO-North America: A randomized controlled trial. JAMA, 2006; 295: 761-775.
29. Ramasubbu R: Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases. Med Hypotheses. 2002; 59: 537-551.
30. Rihmer Z, Révai K, Arató M, Perényi A. Two cases of mazindol-induced depression. Amer J Psychiatry, 1984; 141: 1497-1498.
31. Rihmer Z, Akiskal HS. Do antidepressants t (h) reat (en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J Affect Disord, 2006; 94: 3-13.
32. Rihmer Z, Seregi K, Harmati L. A cardiovascularis rizikófaktorok jelentõsége a depresszió kialakulásában. Hypertonia és Nephrológia, 2007; 11: 168-174.
33. Rosenbohm A, Bux CJ, Conneman BJ. Psychosis with sibutramine. J. Clin. Psychopharmacol. 2007; 27: 315-317.
34. Serra G, Fratta W. A possible role for the endocannabioid system in the neurobiology of depression. Clinical Practice and Epidemiology in Mental Health 2007; 3: 25
35. Simon GF, Von Korff M, Saunders K, Miglioretti DL, Crane PK, Van Belle G, Kessler RC. Association between obestiy and psychiatric disorders in the US adult population. Arch Gen Psychiatry, 2006; 63: 824-830.
36. Spiegel K, Leproult R, van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435-1439
37. Spiegel K, Leproult R, L Hermite-Baleriaux M, Copinschi G, Penev PD, van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol and thyreotropin. J Clin Endocrinol Metab 2004; 89: 5762-5771
38. Spiegel K, Tasali E, Penev PD, van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated leptin levels and increased hunger and appetite. Ann Ingtern Med 2004; 141: 846-850
39. Spiegel K, Knutson K, Leproult R, Tasali E, van Cauter E. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J App Physiology 2005; 99: 2008-2019
40. Stunkard AJ, Ferntstrom MH, Price AR, Frank E, Kupfer DJ, Direction of weight change in recurrent depression. Consistency accross episodes. Arch Gen Psychiatry, 1990; 47: 857-860.
41. Su K-P, Huang S-Y, Chiu T-H, Huang K-C, Huang C-L, Chang H-C, Pariante C. M, Omega-3 fatty acids for major depressive disorder during pregnancy: Results from a randomized, double-blind, placebo controlled trial. J Clin Psychiatry, 2008; 69: 644-651.
42. Sublette ME, Hibbels JR, Galfalvy H, Oquendo MA, Mann JJ. Omega-3 polysaturated essential fatty acid status as a predictor of future suicide risk. Amer J Psychiatry, 2006; 163: 1100-1102.
43. Taylor V, MacDonald K, McKinnon MC, Joffe RT, MacQueen, Increased rates of obesity in first-presentation adults with mood disorders over the course of four-year follow-up. J Affect Disord, 2008; 109: 127-131.
44. Teixeira PJR. És Rocha FL. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev. Bras. Psiquiatr. 2007; 29: 330-336.
45. Turek FW. From circadian rhythms to clock genes in depression. Int Clinical Psychopharmacology. 2007; 22 (Suppl 2): S1-8.